Drug-Eluting Coronary-Artery Stents, New England Journal of Medicine, vol.368, issue.3, pp.254-65, 2013. ,
DOI : 10.1056/NEJMra1210816
Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis, The Lancet, vol.379, issue.9824, pp.1393-402, 2012. ,
DOI : 10.1016/S0140-6736(12)60324-9
A Comparison of Bare-Metal and Drug-Eluting Stents for Off-Label Indications, New England Journal of Medicine, vol.358, issue.4, pp.342-52, 2008. ,
DOI : 10.1056/NEJMoa0706258
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), Eur Heart J, vol.35, pp.2541-619, 2014. ,
A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon Versus Paclitaxel-Eluting Stent for the Treatment of Drug-Eluting Stent In-Stent Restenosis, JACC: Cardiovascular Interventions, vol.7, issue.2, pp.204-215, 2014. ,
DOI : 10.1016/j.jcin.2013.08.011
Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial, The Lancet, vol.381, issue.9865, pp.461-467, 2013. ,
DOI : 10.1016/S0140-6736(12)61964-3
SeQuent Please World Wide Registry, Journal of the American College of Cardiology, vol.60, issue.18, pp.1733-1738, 2012. ,
DOI : 10.1016/j.jacc.2012.07.040
Prospective ???real world??? registry for the use of the ???PCB only??? strategy in small vessel de novo lesions, Heart, vol.80, issue.(Suppl K), pp.311-317, 2014. ,
DOI : 10.1136/heartjnl-2013-304881
Angiographic Patterns of In-Stent Restenosis : Classification and Implications for Long-Term Outcome, Circulation, vol.100, issue.18, pp.1872-1880, 1999. ,
DOI : 10.1161/01.CIR.100.18.1872
Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions, Circulation, vol.115, issue.17, pp.2344-2351, 2007. ,
DOI : 10.1161/CIRCULATIONAHA.106.685313
How to use the drug-eluting balloon: recommendations by the German consensus group, EuroIntervention, vol.7, issue.K, pp.125-133, 2011. ,
DOI : 10.4244/EIJV7SKA21
In-Stent Restenosis in the Drug-Eluting Stent Era, Journal of the American College of Cardiology, vol.56, issue.23, pp.1897-907, 2010. ,
DOI : 10.1016/j.jacc.2010.07.028
Current Treatment of In-Stent Restenosis, Journal of the American College of Cardiology, vol.63, issue.24, pp.2659-73, 2014. ,
DOI : 10.1016/j.jacc.2014.02.545
Long-term outcomes after the percutaneous treatment of drug-eluting stent restenosis, JACC Cardiovasc Interv, vol.4, pp.155-64, 2011. ,
A Randomized Comparison of Drug-Eluting Balloon Versus Everolimus-Eluting Stent in Patients With Bare-Metal Stent???In-Stent Restenosis, Journal of the American College of Cardiology, vol.63, issue.14, pp.1378-86, 2014. ,
DOI : 10.1016/j.jacc.2013.12.006
Randomized Trial of Paclitaxel-Versus Sirolimus-Eluting Stents for Treatment of Coronary Restenosis ,
Implantation of a Drug-Eluting Stent With a Different Drug (Switch Strategy) in Patients With Drug-Eluting Stent Restenosis, JACC: Cardiovascular Interventions, vol.5, issue.7, pp.728-765, 2012. ,
DOI : 10.1016/j.jcin.2012.03.017
EES= everolimus-eluting stent; LAD= left anterior descending artery; LCX= left circumflex; RCA= right coronary artery; SES= sirolimus-eluting stent; TIMI= thrombolysis in myocardial infarction; ZES= zotarolimus-eluting stent. Other abbreviations as in table 1. i Percentage of lesions with data available about target stent type ,
Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of Drug-eluting Stent In-Stent Restenosis; PEPCAD DES=Treatment of DES ,
TLR=Target lesion revascularization Other abbreviations as in tables 1, 2, 4 and 5. * Time of follow-up was 6 months for Habara et al 9, months for PEPCAD China ISR 13 and the GARO registry and 12 months for ISAR-DESIRE, p.14 ,